Related Experiment Video

Updated: Jul 17, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Genetic tools to tailor cancer prevention by NSAIDs

Cornelia M Ulrich1, Jeannette Bigler, John D Potter

  • 1Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

Discovery Medicine
|January 20, 2007
PubMed

Insights

Non-steroidal anti-inflammatory drugs (NSAIDs) show promise in cancer prevention but carry risks. Genetic analysis of cyclooxygenase (COX) enzymes could predict individual benefits and toxicity from NSAID use.

Area of Science:

  • Oncology
  • Pharmacology
  • Genetics

Background:

  • Non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin and Celebrex, are recognized for their cancer-preventive properties with regular use.
  • Long-term NSAID administration, which targets cyclooxygenase (COX) enzymes, is associated with significant gastrointestinal (COX-1 inhibition) and cardiovascular (COX-2 inhibition) adverse effects.

Purpose of the Study:

  • To explore the potential of genetic analysis in predicting individual responses to NSAID cancer prevention.
  • To evaluate the correlation between genetic variations in prostaglandin synthesis enzymes and NSAID-induced benefits versus toxicity.

Main Methods:

  • Review of existing studies on NSAID efficacy and side effects in cancer chemoprevention.
  • Analysis of genetic data related to cyclooxygenase (COX) enzymes and prostaglandin synthesis pathways.

Main Results:

  • NSAIDs demonstrate effectiveness as cancer preventive agents.
  • Inhibition of COX-1 and COX-2 by NSAIDs is linked to specific adverse events.
  • Genetic profiling of prostaglandin synthesis enzymes may offer predictive insights.

Conclusions:

  • Genetic analysis of enzymes in prostaglandin synthesis holds potential for personalized NSAID treatment strategies.
  • Predicting patient-specific benefits and toxicity from NSAIDs can be achieved through genetic assessment.
  • This approach could optimize the use of NSAIDs for cancer prevention while minimizing adverse effects.

More Related Videos

Assessing Specificity of Anticancer Drugs In Vitro09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...